GLP Watchdog

Hims vs Midi Health

Hims has an open FDA warning letter dated September 9, 2025. Midi Health has none. Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. Hims starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hims / Midi Health

Hims logo

Hims

6.7/10

Midi Health logo

Midi Health

4.9/10

FDA warning letters
None on record
Pharmacy
  • Precision Compounding Pharmacytype not stated
Lowest standing price
$149/moBrand-name semaglutide pill, medication only, membership extra
No GLP-1 price published
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Hims
Visit Midi Health

Neither Hims nor Midi Health pays us. Links to them earn nothing. Scores: Hims 6.7, Midi Health 4.9. How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Midi Health has none.

  2. 02

    Midi Health names Precision Compounding Pharmacy. Hims sells brand-name medication only.

  3. 03

    Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. Hims starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

  4. 04

    Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Hims states you can cancel at any time; Midi Health does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hims

Midi Health

Brand-name semaglutide pen

$199/mo

medication only, membership extra; not compared

Not sold or not priced
Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Brand-name semaglutide pill

$149/mo

medication only, membership extra; not compared

Not sold or not priced
Foundayo (orforglipron) pill

$149/mo

medication only, membership extra; not compared

Not sold or not priced
Price includes
Medication
Not stated
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Not stated
Minimum term
Monthly membership, auto-renews
Not stated
Refunds
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Payments are non-refundable; an order may be canceled before shipment at Midi's discretion
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Hims: October 17, 2026. Midi Health: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Midi Health does not price
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

The case for Midi Health

4.9/10
  • No FDA warning letter on record
  • Publishes no GLP-1 price
Visit Midi Health

Scores

Hims 6.7 · Midi Health 4.9 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

6.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Hims vs Midi Health: questions

Hims has an open FDA warning letter dated September 9, 2025. Midi Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Midi Health names Precision Compounding Pharmacy. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed. Midi Health does not state its cancellation terms.
Neither Hims nor Midi Health pays us. Links to them earn nothing. Scores: Hims 6.7, Midi Health 4.9.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks